Clinical Trial Update: Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing radiotherapy with cetuximab plus Xevinapant versus radiotherapy with cetuximab plus placebo in head and neck squamous cell carcinoma h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)
• Xevinapant (Xevinapant)

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: TERMINATED